» Articles » PMID: 28123812

Evaluation of Astrocytoma Cell Proliferation Using Diffusion-weighted Imaging: Correlation with Expression of Proliferating Cell Nuclear Antigen

Overview
Journal Transl Neurosci
Specialty Neurology
Date 2017 Jan 27
PMID 28123812
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to analyze if there is a significant correlation between the results of diffusion-weighted imaging (DWI) and the expression of proliferating cell nuclear antigen (PCNA) in astrocytomas. The DWI scans of 19 different-grade astrocytomas were obtained on a 3 T magnetic resonance scanner. The average regional apparent diffusion coefficients (ADC) were measured. The positive expression of PCNA was determined immunohistochemically by using streptavidin-peroxidase complex staining, and was quantified by calculating its calibrated opacity density (COD) using an image analysis system. The average regional ADC and PCNA COD of low grade and high grade astrocytomas were compared. Correlations between regional ADC and PCNA COD were analyzed. The average regional ADC of high grade astrocytomas was significantly (t = 10.169, P = 0.000) less (0.687 ± 0.225 × 10 mm/s) than that of low grade astrocytomas (1.572 ± 0.333 × 10 mm/s). The PCNA COD (0.343 ± 0.052) of high grade astrocytomas was significantly (t=-7.858, P=0.000) greater than that (0.194 ± 0.012) of low grade astrocytomas. There were strong negative correlations between regional ADC and PCNA COD (r = -0.801, P = 0.000). The results demonstrated that DWI is helpful in evaluating cell proliferation and preoperatively grading astrocytomas by measuring regional ADC.

Citing Articles

The role of ADC value and Ki-67 index in predicting the response to neoadjuvant chemotherapy in advanced stages of olfactory neuroblastoma.

Wang Y, Zhang S, Yu W, Wang Y, Yan F, Yang B Br J Radiol. 2022; 95(1140):20220367.

PMID: 36240450 PMC: 9733604. DOI: 10.1259/bjr.20220367.


miR-137 acts as a tumor suppressor via inhibiting CXCL12 in human glioblastoma.

Li D, Shan W, Fang Y, Wang P, Li J Oncotarget. 2017; 8(60):101262-101270.

PMID: 29254162 PMC: 5731872. DOI: 10.18632/oncotarget.20589.

References
1.
Tang Y, Dundamadappa S, Thangasamy S, Flood T, Moser R, Smith T . Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma. AJR Am J Roentgenol. 2014; 202(6):1303-8. DOI: 10.2214/AJR.13.11637. View

2.
Ko H, Wang Y, Fong W, Chi M, Chi K, Kao S . Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trial. Thorac Cancer. 2016; 5(6):500-8. PMC: 4704334. DOI: 10.1111/1759-7714.12117. View

3.
Chen Z, Ma L, Lou X, Zhou Z . Diagnostic value of minimum apparent diffusion coefficient values in prediction of neuroepithelial tumor grading. J Magn Reson Imaging. 2010; 31(6):1331-8. DOI: 10.1002/jmri.22175. View

4.
Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View

5.
Holodny A, Makeyev S, Beattie B, Riad S, Blasberg R . Apparent diffusion coefficient of glial neoplasms: correlation with fluorodeoxyglucose-positron-emission tomography and gadolinium-enhanced MR imaging. AJNR Am J Neuroradiol. 2010; 31(6):1042-8. PMC: 7963953. DOI: 10.3174/ajnr.A1989. View